Format

Send to

Choose Destination
J Autism Dev Disord. 2007 Apr;37(4):703-8.

Systematic screening for subtelomeric anomalies in a clinical sample of autism.

Author information

1
Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA. thomas-wassink@uiowa.edu

Abstract

High-resolution karyotyping detects cytogenetic anomalies in 5-10% of cases of autism. Karyotyping, however, may fail to detect abnormalities of chromosome subtelomeres, which are gene rich regions prone to anomalies. We assessed whether panels of FISH probes targeted for subtelomeres could detect abnormalities beyond those identified by karyotyping in 104 individuals with Pervasive Developmental Disorders (PDDs) drawn from a general clinical population. Four anomalies were detected by karyotyping, while no additional anomalies were detected by subtelomere FISH or by probes targeted for 15q11.2q13 or 22q11.2 in subgroups of our sample. We conclude that while karyotyping may be more broadly indicated for autism than previously supposed, subtelomere FISH appears less likely to be a useful screening tool for unselected PDD populations.

PMID:
17004120
DOI:
10.1007/s10803-006-0196-9
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center